Company Profile
Zhejiang Jingxin Pharmaceutical researches and develops, produces, and sells pharmaceutical products and medical devices in China and globally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products
API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, ticagrelor, rivaroxaban, apixaban, cisapride, levetiracetam, brivaracetam, sertraline HCI, rivastigmine bitartrate, pramipexole dihydrochloride, memantine hydrochloride, empagliflozin, dapagliflozin, marbofloxacin, and moxifloxacin, as well as intermediates; and medical display products, such as diagnostic medical displays, endoscopy, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, medical imaging solutions, ultrasonic medical displays, and products. Founded in 1990 and headquartered in Xinchang, China, Zhejiang Jingxin Pharmaceutical was formerly known as Zhejiang Jingxin Pharmaceutical Factory before rebranding in 2000.